title: Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells.
abstract: The high mobility group (HMG) proteins (HMGA1a, HMGA1b, and HMGA2) bind to DNA and interact with various transcriptional factors. Therefore, they play an important role in chromatin organization. HMGA protein expression is low in normal adult tissues, but abundant during embryonic development and in several experimental and human tumors. Blockage of HMGA expression inhibits the transformation of rat thyroid PC Cl 3 cells treated with oncogene-carrying retroviruses, thus implicating HMGA in rat thyroid transformation. To better understand the role of HMGA and to establish whether its up-regulated expression is sufficient to induce the transformed phenotype, we generated PC Cl 3 cells that overexpress the protein. We demonstrate that HMGA1b protein overexpression does not transform normal rat thyroid PC Cl 3 cells, but it deregulates their cell cycle: cells enter S-phase earlier and the G(2)-M transition is delayed. HMGA1-overexpressing cells undergo apoptosis through a pathway involving caspase-3 activation, probably consequent to the conflict between mitogenic pressure and the inability to proceed through the cell cycle. Using various HMGA1b gene mutations, we found that the third AT-hook domain and the acetylation site K60 are the protein regions required for induction of apoptosis in PC Cl 3 cells. In conclusion, although HMGA1 protein overexpression is associated with the malignant phenotype of rat and human thyroid cells, it does not transform normal thyroid cells in culture but leads them to programmed cell death.
authors.affiliation: Centro di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, Dipartimento di Patologia Cellulare e Molecolare, Università degli Studi di Napoli Federico II, via Pansini 5, 80131 Naples, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Fedele
authors.forename: G M
authors.initials: GM
authors.lastname: Pierantoni
authors.forename: M T
authors.initials: MT
authors.lastname: Berlingieri
authors.forename: S
authors.initials: S
authors.lastname: Battista
authors.forename: G
authors.initials: G
authors.lastname: Baldassarre
authors.forename: N
authors.initials: N
authors.lastname: Munshi
authors.forename: M
authors.initials: M
authors.lastname: Dentice
authors.forename: D
authors.initials: D
authors.lastname: Thanos
authors.forename: M
authors.initials: M
authors.lastname: Santoro
authors.forename: G
authors.initials: G
authors.lastname: Viglietto
authors.forename: A
authors.initials: A
authors.lastname: Fusco
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D016203:CDC2 Protein Kinase / Q000378:metabolism; D002453:Cell Cycle / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000378:metabolism / Q000473:pathology; D016213:Cyclins / Q000096:biosynthesis; D018076:DNA, Complementary / Q000235:genetics; D015870:Gene Expression; D006609:High Mobility Group Proteins / Q000096:biosynthesis* / Q000235:genetics; D010449:Peptide Mapping; D020033:Protein Isoforms; D051381:Rats; D013961:Thyroid Gland / Q000166:cytology* / Q000378:metabolism*; D014162:Transfection
chemical_list: D016213:Cyclins; D018076:DNA, Complementary; D006609:High Mobility Group Proteins; D020033:Protein Isoforms; D016203:CDC2 Protein Kinase